Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127363181 | 12736318 | 1 | I | 20160829 | 20160913 | 20160913 | EXP | US-MLMSERVICE-20160824-0402919-1 | US-ALKEM LABORATORIES LIMITED-US-ALKEM-2016-00168 | ALKEM | 16.00 | YR | F | Y | 0.00000 | 20160913 | CN | GB | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127363181 | 12736318 | 1 | PS | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 400 MG, UNK | 78925 | 400 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127363181 | 12736318 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127363181 | 12736318 | LT |
| 127363181 | 12736318 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127363181 | 12736318 | Acute kidney injury | |
| 127363181 | 12736318 | Blood lactic acid increased | |
| 127363181 | 12736318 | Cardiogenic shock | |
| 127363181 | 12736318 | Coma scale abnormal | |
| 127363181 | 12736318 | Hypotension | |
| 127363181 | 12736318 | Overdose | |
| 127363181 | 12736318 | Tachycardia | |
| 127363181 | 12736318 | Troponin increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |